A randomized controlled trial for the fire acupuncture in the treatment of malignant pleural effusio

Phase 1

• Conditions: malignant pleural effusion

• Registration Number: ITMCTR1900002848
• Lead Sponsor: Guangxi Traditional Chinese Medical University Affiliated First Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. meet the above diagnostic criteria;
2. Aged 20 ~ 70 years old;
3. X-ray or b-ultrasound showed malignant pleural effusion;
4. the survival time is expected to be more than 3 months;
5. ECOG PS score <=3 points, expected survival >=3 months;
6. no chemotherapy or intrathoracic drug injection was given within 1 month before the inclusion of treatment;
7. participate in the study voluntarily and sign the informed consent.

Exclusion Criteria

1. diagnosis of pleural effusion caused by unknown or simple hypoproteinemia;
2. routine blood tests showed that white blood cells were less than 3.5*109/L, hemoglobin was less than 80g/L, or platelets were less than 80*10^9/L;
3. severe pulmonary infection;
4. those with KPS score < 50 and estimated survival period < 3 months;
5. patients with abnormal fluid quality or multiple organ failure;
6. severe damage to the heart, liver or kidney or abnormal bone marrow function;
7. poor coagulation function, prone to massive bleeding;
8. patients with severe heart, brain, kidney and liver diseases;
9. patients cannot accept and tolerate fire needle therapy;
10. patients with mental problems who cannot cooperate.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptom remission rate;